Guardant Health
346 hedge funds and large institutions have $9.55B invested in Guardant Health in 2020 Q3 according to their latest regulatory filings, with 69 funds opening new positions, 119 increasing their positions, 109 reducing their positions, and 46 closing their positions.
50% more first-time investments, than exits
New positions opened: 69 | Existing positions closed: 46
39% more capital invested
Capital invested by funds: $6.85B → $9.55B (+$2.7B)
6% more funds holding
Funds holding: 325 → 346 (+21)
9% more repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 109
0.06% more ownership
Funds ownership: 85.91% → 85.97% (+0.06%)
1% less call options, than puts
Call options by funds: $66.2M | Put options by funds: $66.9M
50% less funds holding in top 10
Funds holding in top 10: 8 → 4 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$72M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$68M |
| 3 |
Goldman Sachs
New York
|
+$45.4M |
| 4 |
RI
RTW Investments
New York
|
+$42.9M |
| 5 |
SCM
Suvretta Capital Management
New York
|
+$41.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
-$53.7M |
| 2 |
MWNA
Marshall Wace North America
New York
|
-$42.8M |
| 3 |
Coatue Management
New York
|
-$41.8M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$37M |
| 5 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
-$27.2M |
GH Hedge Fund Activity: Q3 2020 in Review
346 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Guardant Health (GH) for Q3 2020, worth a combined $9.55B — up 39% from $6.85B a quarter earlier.
Buyers outnumbered sellers: 69 funds opened new GH positions and 46 closed out — a net gain of 23 holders — while 119 added to existing stakes and 109 trimmed.
The largest buyer was Viking Global Investors, adding an estimated $72M. The largest seller was Marshall Wace, cutting an estimated $53.7M.
- 346 institutional investors held Guardant Health (GH) as of Q3 2020, up from 325 in Q2 2020.
- Funds reported $9.55B of Guardant Health stock for Q3 2020, up 39% quarter-over-quarter.
- 69 funds opened new Guardant Health positions in Q3 2020 and 46 closed out, a net change of +23 holders.
- The largest Guardant Health buyer in Q3 2020 was Viking Global Investors, an estimated $72M added.
- The largest Guardant Health seller in Q3 2020 was Marshall Wace, an estimated $53.7M sold.
Based on aggregated 13F filings for Q3 2020.